Evolent Health, Inc. (EVH)
Total Valuation
Evolent Health has a market cap or net worth of $3.73 billion. The enterprise value is $4.16 billion.
Market Cap | 3.73B |
Enterprise Value | 4.16B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Evolent Health has 115.43 million shares outstanding. The number of shares has increased by 18.73% in one year.
Shares Outstanding | 115.43M |
Shares Change (YoY) | +18.73% |
Shares Change (QoQ) | +1.18% |
Owned by Insiders (%) | 4.17% |
Owned by Institutions (%) | 112.02% |
Float | 109.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 26.26 |
PS Ratio | 1.90 |
Forward PS | 1.49 |
PB Ratio | 3.49 |
P/FCF Ratio | 32.73 |
PEG Ratio | -1.37 |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.12 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 36.58 |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.60.
Current Ratio | 1.01 |
Quick Ratio | 0.97 |
Debt / Equity | 0.60 |
Debt / EBITDA | n/a |
Debt / FCF | 5.66 |
Interest Coverage | -2.73 |
Financial Efficiency
Return on equity (ROE) is -13.00% and return on invested capital (ROIC) is -3.11%.
Return on Equity (ROE) | -13.00% |
Return on Assets (ROA) | -5.40% |
Return on Capital (ROIC) | -3.11% |
Revenue Per Employee | $417,850 |
Profits Per Employee | -$30,268 |
Employee Count | 4,700 |
Asset Turnover | 0.74 |
Inventory Turnover | n/a |
Taxes
Income Tax | -89.37M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.20% in the last 52 weeks. The beta is 1.54, so Evolent Health's price volatility has been higher than the market average.
Beta (1Y) | 1.54 |
52-Week Price Change | +4.20% |
50-Day Moving Average | 31.81 |
200-Day Moving Average | 29.31 |
Relative Strength Index (RSI) | 50.75 |
Average Volume (30 Days) | 999,037 |
Short Selling Information
The latest short interest is 11.24 million, so 9.74% of the outstanding shares have been sold short.
Short Interest | 11.24M |
Short Previous Month | 11.19M |
Short % of Shares Out | 9.74% |
Short % of Float | 10.30% |
Short Ratio (days to cover) | 9.94 |
Income Statement
In the last 12 months, Evolent Health had revenue of $1.96 billion and -$142.26 million in losses. Loss per share was -$1.28.
Revenue | 1.96B |
Gross Profit | 460.47M |
Operating Income | -53.23M |
Pretax Income | -202.41M |
Net Income | -142.26M |
EBITDA | -24.79M |
EBIT | -148.20M |
Loss Per Share | -$1.28 |
Balance Sheet
The company has $206.59 million in cash and $644.80 million in debt, giving a net cash position of -$438.20 million or -$3.80 per share.
Cash & Cash Equivalents | 206.59M |
Total Debt | 644.80M |
Net Cash | -438.20M |
Net Cash Per Share | -$3.80 |
Equity / Book Value | 1.07B |
Book Value Per Share | 9.25 |
Working Capital | 9.43M |
Cash Flow
In the last 12 months, operating cash flow was $142.58 million and capital expenditures -$28.75 million, giving a free cash flow of $113.84 million.
Operating Cash Flow | 142.58M |
Capital Expenditures | -28.75M |
Free Cash Flow | 113.84M |
FCF Per Share | $1.02 |
Margins
Gross margin is 23.45%, with operating and profit margins of -2.71% and -7.24%.
Gross Margin | 23.45% |
Operating Margin | -2.71% |
Pretax Margin | -10.31% |
Profit Margin | -7.24% |
EBITDA Margin | -1.26% |
EBIT Margin | -7.55% |
FCF Margin | 5.80% |
Dividends & Yields
Evolent Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.73% |
Shareholder Yield | -18.73% |
Earnings Yield | -3.82% |
FCF Yield | 3.06% |
Analyst Forecast
The average price target for Evolent Health is $42.63, which is 30.25% higher than the current price. The consensus rating is "Buy".
Price Target | $42.63 |
Price Target Difference | 30.25% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 13.02% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Evolent Health has an Altman Z-Score of 1.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.74 |
Piotroski F-Score | 3 |